Related content

T cell depletion of allogeneic stem cell grafts with anti-CD 52 monoclonal antibodies: the Ulm experience from 1983-1999

By Bunjes D.  

Transfusion and Apheresis Science, Vol. 23, Iss. 2, 2000-10 ,pp. : 151-162

Elsevier

Access to resources Recommend Favorite

T-cell depletion of allogeneic bone marrow using anti- TCR monoclonal antibody - biology and transplantation

By Neipp M.   Exner B.G.   Maru D.   Haber M.   Gammie J.S.   Pham S.M.   Ildstad S.T.  

Experimental Hematology, Vol. 27, Iss. 5, 1999-05 ,pp. : 860-867

Elsevier

Access to resources Recommend Favorite

The inhibitory effect of anti-CD33 monoclonal antibodies on AML cell growth correlates with Syk and/or ZAP-70 expression

By Balaian L.   Zhong R.-k.   Ball E.D.  

Experimental Hematology, Vol. 31, Iss. 5, 2003-05 ,pp. : 363-371

Elsevier

Access to resources Recommend Favorite

Investigation of the immunosuppressive potential of anti-CD28 antibodies for selective inhibition of the T-cell mediated alloresponse

By Otto C.   Feuerlein S.   Timmermann W.   Ulrichs K.   Hunig T.   Thiede A.   Gassel H.J.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2376-2376

Elsevier

Access to resources Recommend Favorite

Mice treated with Anti-CD4 monoclonal antibody accept fully allogeneic thyroid grafts but reject second-donor-type thyroid grafts in maintenance phase

By Niimi M.   Takashina M.   Ikeda Y.   Shirasugi N.   Shatari T.   Takami H.   Kodaira S.   Kameyama K.   Matsumoto K.   Hamano K.   Esato K.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2086-2086

Elsevier

Access to resources Recommend Favorite